查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827864

互联医疗设备市场（按产品类型、应用、最终用户、连接技术和分销管道划分）—2025-2032 年全球预测

Connected Medical Devices Market by Product Type, Application, End User, Connectivity Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，连网医疗设备市场将成长至 2,913.7 亿美元，复合年增长率为 23.24%。

主要市场统计数据
基准年2024年 547.5亿美元
预计2025年 672.6亿美元
预测年份：2032年 2913.7亿美元
复合年增长率（%） 23.24%

整合感测、分析和连结如何改变临床工作流程、产品设计优先顺序和上市动态的策略概述

互联医疗设备正在重塑医疗服务，它融合了感测、分析和连接技术，将临床监测扩展到传统医疗环境之外。这种硬体、软体和云端服务的整合正在催生持续监测模式，从而开闢新的护理途径，实现早期发现和干预，减少住院时间，并改善慢性病管理。因此，设备製造商、数位医疗公司和医疗服务提供者必须将产品开发与临床工作流程、互通性标准和网路安全态势同步。

在整个生态系统中，创新不再只涉及组件的改进，而需要係统思维来协调使用者体验、法规遵循和资料生命週期管理。随着连网型设备的临床和商业性价值不断提升，组织必须面临复杂的权衡：如何在设备小型化和电池寿命与数据保真度之间取得平衡，如何将软体功能发布的节奏与证据生成同步，以及如何协调将设备销售与持续性服务相结合的收益模式。有效的应对措施需要工程、临床、监管和商业团队之间的跨职能协作。

相关人员也在不断变化的政策和贸易环境中运作，这可能会影响采购、製造和分销决策。总而言之，这些动态既为大规模提供差异化患者治疗方案的能力创造了机会，也带来了风险，同时也带来了供应链中断、网路威​​胁和报销不确定性。本介绍将透过识别组织必须应对的策略曲折点，为后续的综合分析奠定基础，以便从互联医疗设备中获取长期价值。

加速软体成熟度、先进的连接标准和不断变化的报销模式如何重新定义竞争优势和监管义务

互联医疗设备领域正在经历一系列变革，这些变革时期正在重新定义竞争优势、监管预期和医疗服务交付模式。首先，嵌入式软体和人工智慧主导分析的成熟度曲线正从原型实验阶段转向临床可行能力，这迫使製造商采用生命週期方法进行软体检验、上市后效能监控和演算法管治。因此，产品蓝图现在将临床证据生成和可解释性作为核心商业需求，而非可选功能。

其次，低功率广域网路和高吞吐量行动电话标准的普及正在扩大远端监控和远端医疗整合的覆盖范围。这种连接性的演进使设备能够在分散式护理模式下运行，比前几代设备具有更低的延迟、更丰富的远端检测和更高的可靠性。这也强化了句法和语义互通性的重要性，以便患者资料能够在不同的医疗IT系统之间进行聚合、标准化和利用。

第三，报销和采购实践正逐步适应基于价值的模式，为那些能够显着降低急性病护理利用率并改善慢性病治疗效果的设备提供奖励。同时，监管机构正在完善关于软体作为医疗设备、网路安全风险管理和真实世界效能证据的指导，迫使製造商将监管策略整合到其产品开发週期中。

最后，随着设备製造商、云端服务供应商和临床网路之间策略联盟的蓬勃发展，市场结构也在改变。这些联盟加速了市场进入，但也带来了新的依赖关係和责任共用。这种转变的最终结果是，市场竞争格局的形成取决于临床检验、连结整合和上市后管理方面的敏捷性，从而区分市场领导者和后进企业。

关税对联网医疗设备相关人员的采购、产品设计和供应链弹性的营运和策略影响

近期针对医疗设备投入品和成品的贸易行动，给製造商和供应商带来了复杂的成本、采购和调度压力。关税加上互惠贸易回应，正在改变零件和组装的原产地计算方式，促使企业重新评估其供应商组合，增加库存缓衝，并加速近岸外包和双重采购策略。这些调整对下游领域也产生了影响，包括前置作业时间、品管流程以及用于製造升级的资本配置。

从商业角度来看，某些零件的关税上调可能会增加设备的实际到岸成本，除非透过价格调整、降低供应商成本或转向替代材料来抵消，否则可能会压缩净利率。面临关税影响的製造商通常会进行重新设计，以从其他司法管辖区采购的功能等效的替代品来取代受关税影响的零件。此类重新设计通常涉及更新的合格测试和监管备案，从而导致时间安排超出当前商业週期。

应对关税环境的策略性倡议各不相同。一些组织选择在优惠的关税管辖区内整合高价值组件，而另一些组织则透过服务合约或管理式医疗安排来建立价格弹性，从而转移部分成本负担。同时，采购团队强调在关税上涨的情况下保留重新谈判权利的合约条款，并鼓励签订长期供应协议以确保产能。

重要的是，关税也会影响创新轨迹。如果零件成本上升，开发重点可能会转向利润率更高的设备、软体驱动的服务层或受跨境关税影响较小的售后市场耗材。同时，围绕贸易措施的政策不确定性提升了情境规划和产品系列压力测试的价值，使企业能够在其他关税轨迹下保持业务连续性和市场进入。

详细的細項分析将产品子类、临床用途、最终用户环境、连接方式和分销管道与采用槓桿联繫起来

细粒度的细分揭示了产品设计、临床使用、最终用户环境、连接选项和分销策略如何影响采用动态和商业性优先顺序。按产品类型（诊断、监测、手术、治疗和穿戴式装置）细分市场反映了临床医生和患者的细微需求。诊断设备，特别是成像系统、就地检验套件和超音波系统，需要高诊断准确性、强大的校准工作流程以及与影像归檔和通讯系统的互通性。监测设备（例如心电图监测仪、血糖监测仪和生命征象监测仪）优先考虑持续性资料完整性、电源管理和警报管理，以支援临床决策。手术设备（例如电外科设备、内视镜设备和机器人手术系统）需要严格的可靠性、无菌相容性以及与手术室资讯学的无缝整合。治疗设备（例如透析系统、输液帮浦和人工呼吸器）优先考虑安全冗余、剂量准确性和故障安全机制。健身追踪器和智慧型手錶等穿戴式装置平衡了消费者人体工学、感测器保真度和无缝行动连线，以鼓励持续使用。

基于应用的细分进一步明确了药物传输、诊断影像、病患监测、復健、手术辅助和远端医疗的价值提案。在药物传递方面，输液给药、吸入系统和注射给药之间的差异会影响设备外形规格、依从性监测以及与电子药历的连接性。 CT、MRI、超音波影像影像和X光等诊断影像方式分别涉及不同的监管途径、资本密集度和临床医师训练需求。病患监测包括门诊监测、重症患者监测和远端监测，每种方式都有不同的讯号撷取优先顺序、延迟接受度以及与临床工作流程的整合需求。从神经復健到职业治疗和物理治疗的復健应用利用感测器和回馈迴路来量化结果并支持远距照护。导航系统和机器人手术辅助强调精密动态、即时影像处理和外科医生介面设计的整合。在远端医疗领域，远距离诊断、远端患者监护和视讯咨询等子领域强调了无缝、安全的资料交换和清晰的升级路径的必要性。

最终使用者群体（例如门诊护理中心、诊所、诊断中心、居家照护机构和医院）决定了采购週期和支援要求。居家照护机构（包括老年护理和术后护理）优先考虑易用性、看护者支援和远端临床医生监控。公立和私立医院都需要规模、服务水准协议以及临床和经济效益证据来支持资本投资。连接技术的选择——蓝牙（包括 BLE 和传统蓝牙）、从 2G 到 5G 的蜂窝标准、NFC、Wi-Fi（802.11ac 和 802.11n）和 Zigbee——决定了设备的互通性、通讯、范围和安全架构。最后，线下和线上通路之间的差异会影响客户体验、安装服务和售后支援。虽然线上管道加速了初始采购，但线下管道对于复杂的设备安装和培训通常至关重要。

影响美洲、欧洲、中东和非洲以及亚太市场商业化、监管策略和供应链选择的区域考量

区域动态显着影响互联医疗设备的需求驱动因素、监管要求和上市执行。在美洲，成熟的报销体系、先进的医院基础设施以及对远端监控的强烈需求，共同支撑了那些在降低急性护理利用率方面展现出显着价值的设备。该地区还拥有强大的私人和公共支付机构网络，这有望加速慢性病管理和急性后期护理中设备的普及。同时，供应链物流和与零件供应商的接近性使美洲成为近岸外包和快速产品迭代的中心。

欧洲、中东和非洲是一个多元化的环境，监管协调工作和多样化的采购模式并存。许多欧洲市场需要透过集中采购和医疗技术评估流程获得强有力的临床和经济证据，而中东和非洲市场预计将在私人医院扩张和数位医疗基础设施投资的推动下实现高速成长。在全部区域，资料保护标准和互通性工作影响设备设计和云端架构的决策，因此需要製定适应性监管策略和针对特定地区的支援模式。

亚太地区涵盖了广泛的成熟度水平，从拥有强大国内製造生态系统的已开发市场，到正在透过数位优先部署超越传统基础设施的快速发展的医疗保健系统。该地区的规模和多样性为可扩展、低成本的设备变体和模组化平台创造了机会，这些平台可以根据本地临床需求进行客製化。此外，委託製造和电子产品供应商的丰富资源支援成本优化策略，而不断发展的报销框架和庞大的患者群体为远端监控和远端医疗解决方案提供了肥沃的土壤。总而言之，区域洞察凸显了差异化商业化策略的必要性，这些策略应将证据生成、供应链设计和伙伴关係生态系统与本地市场实际情况相结合。

分析现有企业和挑战者的策略，强调平台化、伙伴关係和以证据主导的商业化，以扩大连网设备供应

互联医疗设备领域的主要企业展现出一致的模式，即将软体和服务整合到其核心产品中，优先考虑网路安全和法规遵从性，并建立生态系统伙伴关係以扩大临床覆盖范围。市场领先的公司投资模组化平台，以实现快速功能部署和第三方集成，同时保持严格的软体更新和上市后监测变更控制流程。他们的研发方法强调临床协作、与医疗系统的试点部署以及迭代检验，以建立临床医生的信任和报销途径。

规模较小的公司通常专注于利基临床问题，并利用敏捷性来迭代使用者介面，从而加快上市时间。这些公司通常寻求与云端和分析提供者合作，以补充其内部能力，并与通路经销商和医疗系统合作，以获得初步规模。许多此类公司采用混合经营模式，将设备销售与分析订阅、远端监控服务和耗材的经常性收益相结合。

纵观竞争格局，我们看到传统设备製造商与数位健康专家之间的策略联盟日益增加。这些联盟加速了资料科学能力、病人参与工具和人口健康管理平台的取得。同时，非传统参与企业优先考虑速度和体验设计，但必须快速开发临床检验流程和监管专业知识，以保持可持续的竞争优势。总而言之，这些公司层面的行动凸显了整合临床证据、强大的网路安全和伙伴关係主导的分销管道，在复杂的医疗环境中有效扩展规模的竞争必要性。

製造商和供应商应采取实际的策略倡议，以增强产品开发、供应链弹性以及连网型设备的上市模式

为了从互联医疗设备中获取长期价值，产业领导者应采取三管齐下的方法，将产品策略、营运韧性和上市计画协调一致。首先，在产品开发早期就纳入监管和临床证据规划，以推动软体迭代、演算法更新和硬体修订，同时最大限度地减少下游摩擦。主动规划可以加快新功能的上市时间，并在结果数据可用时增强与付款人的对话。

其次，重新设计您的供应链和筹资策略，以增强抵御贸易中断和关税带来的成本压力的能力。这包括实现零件供应商多元化，在可行的情况下筛选合格的替代材料，并评估关键组件的近岸外包。同时，调整您的采购合同，纳入关税转嫁的灵活条款，并为面临波动性贸易风险的关键零件建立策略性库存缓衝。

第三，我们将优先考虑互通性、网路安全和以使用者为中心的设计，以加速医疗机构的采用。我们将投资开放API、基于标准的资料模型和严格的采用测试，同时进行以临床医生为中心的可用性研究，以最大限度地减少培训负担。同时，我们将开发一种将设备销售与订阅服务结合的商业模式，以较低的前期成本为客户提供可预测的收益。

最后，我们与付款人、医疗系统和技术提供者建立策略伙伴关係，共同开发报销途径和综合护理计划。我们进行试点部署，收集现实世界证据，以支持报销谈判并扩大临床适应症。透过实施这些建议，企业可以降低营运风险，提高产品与市场的契合度，并将连网型设备的力量转化为永续的商业性优势。

我们的透明研究途径结合了相关人员访谈、技术评估、监管审查和情境测试，以检验连网型设备洞察。

支撑本分析的研究综合了主要相关人员访谈、技术产品评估、政策和监管审查以及二手文献整合，旨在提供对互联医疗设备格局的整体视角。主要输入包括与临床医生、采购负责人、监管专家和设备工程师进行的结构化访谈，以根据营运现状和证据需求提供见解。这些访谈也辅以对代表性设备架构、连接堆迭和网路安全态势的技术评估，以突显反覆出现的工程约束和整合模式。

监管和政策审查流程考察了目前关于软体作为医疗设备的指导、网路安全要求以及影响医疗技术供应链的贸易措施。审查还结合了区域采购机制和报销框架的比较分析，以评估证据阈值和购买行为在不同市场之间的差异。我们也进行了二手文献和上市公司分析，以检验公司策略并分析产业趋势，并运用成功的试点案例来阐述规模化发展路径。

此分析方法将定性主题编码与基于情境的压力测试相结合，以评估对资费变化、连接性变化和监管更新的敏感性。在适用的情况下，我们采用证据层级结构来衡量临床研究、试验结果和实际表现数据。在整个过程中，我们始终保持假设和资料来源的透明度，以确保可复製性，并支持客户后续问题，从而更深入地了解特定产品和区域的细微差别。

将联网医疗设备创新转化为持续临床价值和商业性成功的系统性要求的总结性观点

互联医疗设备代表着医疗保健转型的关键前沿，为更早诊断、持续慢性病管理以及更有效率地利用临床资源提供了途径。先进感测技术、嵌入式软体和无所不在的连接技术的融合，正在推动人们对产品设计、证据产生和上市后管理的全新期望。能够将临床检验、网路安全和互通性与弹性供应链同步的组织，将占据有利地位，从而扩大市场规模并保持市场优势。

但未来之路充满挑战。关税和贸易不确定性迫使企业重新评估筹资策略和成本结构，而不断变化的监管和报销格局则要求严谨的证据规划。市场领导者正透过产品平台化、建立策略伙伴关係以及投资于支持临床医生采用和付款人覆盖的真实世界性能证据来应对挑战。成功的关键在于采取一种综合方法，将产品开发、营运和上市流程与可衡量的临床和经济成果相结合。

最后，将互联设备视为系统，并共同设计硬体、软体、临床工作流程和商业模式的医疗保健机构将释放最大的价值。那些对供应链和监管途径实施严格风险管理，同时持续关注用户需求和数据品质的机构，将能够将技术可能性转化为持久的临床影响。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 在联网医疗设备中实施端对端加密通讯协定，以增强网路安全
  • 整合人工智慧演算法，即时分析患者产生的健康数据流
  • 采用标准化的互通性框架，实现跨医疗平台的无缝资料交换
  • 在医疗设备内部署边缘运算架构，以减少延迟并提高治疗回应能力
  • 开发电池优化技术以延长无线医疗监测设备的使用寿命
  • 将语音控制和自然语言处理整合到医疗设备介面以提高可访问性

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 连网医疗设备市场（依产品类型）

  • 诊断设备
    • 影像系统
    • 就地检验套件
    • 超音波设备
  • 监控设备
    • 心电图监测仪
    • 血糖值监测仪
    • 生命征象监测仪
  • 手术设备
    • 电外科设备
    • 内视镜设备
    • 机器人手术系统
  • 治疗设备
    • 透析系统
    • 点滴帮浦
    • 人工呼吸器
  • 穿戴式装置
    • 健身追踪器
    • 智慧型手錶

9. 网路医疗设备市场（按应用）

  • 药物输送
    • 静脉给药
    • 吸入系统
    • 注射药物输送
  • 影像学
    • CT
    • MRI
    • 超音波影像
    • X射线
  • 病患监测
    • 门诊监护
    • 加护治疗监测
    • 远端监控
  • 復原
    • 神经復健
    • 职能治疗
    • 物理治疗
  • 手术援助
    • 导航系统
    • 机器人协助
  • 远端医疗
    • 远距离诊断
    • 远端患者监护
    • 视讯咨询

第 10 章：连网医疗设备市场（按最终用户划分）

  • 门诊治疗中心
  • 诊所
  • 诊断中心
  • 居家照护环境
    • 老年护理
    • 术后护理
  • 医院
    • 私立医院
    • 公立医院

第 11 章：按连接技术分類的连接医疗设备市场

  • Bluetooth
    • BLE
    • 经典蓝牙
  • 蜂巢
    • 2G 3G 4G
    • 5G
  • NFC
  • Wi-Fi
    • 802 11ac
    • 802 11n
  • ZigBee

第 12 章 互联医疗设备市场（依分销管道）

  • 离线
  • 在线的

第 13 章：按地区分類的连网医疗设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第14章 联网医疗设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章：各国连网医疗设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Koninklijke Philips NV
    • General Electric Company
    • Medtronic plc
    • Siemens Healthineers AG
    • Johnson & Johnson
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Baxter International Inc.
    • ResMed Inc.
    • Dexcom, Inc.
Product Code: MRR-43750BE226AB

The Connected Medical Devices Market is projected to grow by USD 291.37 billion at a CAGR of 23.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 54.75 billion
Estimated Year [2025] USD 67.26 billion
Forecast Year [2032] USD 291.37 billion
CAGR (%) 23.24%

A strategic overview of how integrated sensing, analytics, and connectivity are transforming clinical workflows, product design priorities, and market entry dynamics

Connected medical devices are reshaping care delivery by integrating sensing, analytics, and connectivity to extend clinical oversight beyond traditional care settings. This convergence of hardware, software, and cloud-enabled services has cultivated new care pathways, enabled earlier detection and intervention, and fostered continuous monitoring models that reduce hospital stays and improve chronic disease management. The result is a landscape in which device manufacturers, digital health companies, and care providers must synchronize product development with clinical workflows, interoperability standards, and cybersecurity postures.

Across the ecosystem, innovation is no longer confined to component improvements; it now requires systems thinking that aligns user experience, regulatory compliance, and data lifecycle management. As the clinical and commercial value of connected devices increases, organizations must confront complex trade-offs: balancing device miniaturization and battery longevity against data fidelity; reconciling the pace of software feature releases with evidence generation; and harmonizing revenue models that mix device sales with recurring services. Effective responses demand cross-functional collaboration among engineering, clinical, regulatory, and commercial teams.

Stakeholders also operate within an evolving policy and trade environment that can influence sourcing, manufacturing, and distribution decisions. Taken together, these dynamics are creating both opportunity and risk: the capacity to deliver differentiated patient outcomes at scale, and the exposure to supply chain disruption, cyber threats, and reimbursement uncertainty. This introduction sets the stage for an integrated analysis that follows, revealing the strategic inflection points organizations must address to capture long-term value from connected medical devices.

How accelerated software maturity, advanced connectivity standards, and shifting reimbursement models are redefining competitive advantage and regulatory obligations

The connected medical device landscape is undergoing a series of transformative shifts that are redefining competitive advantage, regulatory expectations, and care delivery models. First, the maturity curve of embedded software and AI-driven analytics has moved from prototype experimentation to clinically actionable features, prompting manufacturers to adopt lifecycle approaches to software validation, post-market performance monitoring, and algorithm governance. Consequently, product roadmaps now integrate clinical evidence generation and explainability as core commercial requirements rather than optional capabilities.

Second, the proliferation of low-power wide-area networks and higher-throughput cellular standards is expanding the feasible envelope for remote monitoring and telehealth integration. This connectivity evolution is enabling devices to operate in distributed care models with lower latency, richer telemetry, and greater reliability than prior generations. It also elevates the importance of interoperability-both syntactic and semantic-so that patient data can be aggregated, normalized, and acted upon across disparate health IT systems.

Third, reimbursement and procurement practices are gradually adapting to value-based paradigms, creating incentives for devices that demonstrably reduce acute care utilization and improve chronic disease outcomes. In parallel, regulatory authorities are refining guidance on software as a medical device, cybersecurity risk management, and real-world performance evidence, compelling manufacturers to embed regulatory strategy into product development cycles.

Finally, market structure is shifting as strategic partnerships between device makers, cloud providers, and clinical networks proliferate. These alliances accelerate market access but also introduce new dependencies and shared liabilities. The net effect of these shifts is a competitive landscape where agility in clinical validation, connectivity integration, and post-market stewardship distinguishes market leaders from laggards.

Operational and strategic consequences of tariff measures on sourcing, product design, and supply chain resilience for connected medical device stakeholders

Recent trade measures targeting medical device inputs and finished goods have introduced a complex set of cost, sourcing, and scheduling pressures for manufacturers and suppliers. Tariff actions, coupled with reciprocal trade responses, have changed the calculus for where components and assemblies are produced, prompting firms to reassess supplier portfolios, increase inventory buffers, and accelerate nearshoring or dual-sourcing strategies. These adjustments have downstream effects on lead times, quality control processes, and capital allocation for manufacturing upgrades.

Operationally, increased duties on specific components raise the effective landed cost of devices and can compress margins unless offset by pricing adjustments, supplier cost reductions, or moves to alternative materials. In many cases, manufacturers facing tariff exposure have pursued redesigns that substitute tariffed parts with functionally equivalent alternatives sourced from different jurisdictions. Such redesigns often entail qualification testing and updated regulatory submissions, creating timelines that extend beyond immediate commercial cycles.

Strategic responses to the tariff environment are varied. Some organizations elect to consolidate higher-value assembly within tariff-favored jurisdictions, while others build in pricing elasticity through service contracts and managed care arrangements that shift part of the cost burden. At the same time, procurement teams emphasize contract language that preserves renegotiation rights in the face of tariff escalations and encourage longer-term supply agreements to secure capacity.

Importantly, tariffs also influence innovation pathways. When component costs rise, development priorities may pivot toward higher-margin devices, software-enabled service layers, or aftermarket consumables that are less exposed to cross-border duties. Meanwhile, policy uncertainty surrounding trade measures increases the value of scenario planning and stress-testing for product portfolios, ensuring firms can preserve operational continuity and market access under alternative tariff trajectories.

In-depth segmentation analysis linking product subclasses, clinical applications, end-user environments, connectivity modalities, and distribution channels to adoption levers

Granular segmentation reveals how product design, clinical application, end-user contexts, connectivity choices, and distribution strategies shape adoption dynamics and commercial priorities. When viewed through Product Type lenses such as Diagnostic Devices, Monitoring Devices, Surgical Devices, Therapeutic Devices, and Wearable Devices, the nuanced needs of clinicians and patients emerge. Diagnostic Devices-and specifically imaging systems, point-of-care test kits, and ultrasound devices-demand high diagnostic accuracy, robust calibration workflows, and interoperability with picture archiving and communication systems. Monitoring Devices such as ECG monitors, glucose monitors, and vital signs monitors prioritize continuous data integrity, power management, and alarm management to support clinical decision-making. Surgical Devices, including electrosurgical devices, endoscopic devices, and robotic surgery systems, require exacting reliability, sterile compatibility, and seamless integration with operating room informatics. Therapeutic Devices like dialysis systems, infusion pumps, and ventilators emphasize safety redundancies, dose delivery accuracy, and fail-safe mechanisms. Wearable Devices, represented by fitness trackers and smart watches, balance consumer ergonomics, sensor fidelity, and seamless mobile connectivity to encourage sustained engagement.

Application-based segmentation further clarifies value propositions across drug delivery, imaging, patient monitoring, rehabilitation, surgical assistance, and telehealth. Within drug delivery, distinctions among infusion drug delivery, inhalation systems, and injection drug delivery influence device form factor, adherence monitoring, and connectivity to electronic medication records. Imaging modalities such as CT, MRI, ultrasound imaging, and X-ray carry distinct regulatory pathways, capital intensity, and clinician training requirements. Patient monitoring spans ambulatory monitoring, critical care monitoring, and remote monitoring, each with different signal-capture priorities, latency tolerances, and integration needs with clinical workflows. Rehabilitation applications from neurorehabilitation to occupational therapy and physical therapy leverage sensors and feedback loops to quantify outcomes and support remote care. Surgical assistance via navigation systems and robotic assistance underscores the convergence of precision mechanics, real-time imaging, and surgeon interface design. Telehealth subsegments-remote diagnosis, remote patient monitoring, and video consultation-highlight the need for seamless, secure data exchange and clear escalation pathways.

End-user segmentation across ambulatory care centers, clinics, diagnostic centers, home care settings, and hospitals shapes procurement cycles and support requirements. Home care settings, which include elderly care and post-operative care, prioritize ease of use, caregiver support, and remote clinician oversight. Hospitals, whether private or public, demand scale, service-level agreements, and evidence of clinical and economic benefit to support capital investments. Connectivity Technology choices-Bluetooth (including BLE and Classic Bluetooth), cellular standards spanning 2G through 5G, NFC, Wi-Fi (802.11ac and 802.11n), and Zigbee-determine device interoperability, power consumption, range, and security architecture. Finally, Distribution Channel differentiation between offline and online pathways influences customer experience, installation services, and aftermarket support, with online channels accelerating initial procurement but offline channels often remaining critical for complex device installation and training.

Regional considerations that shape commercialization, regulatory strategy, and supply chain choices across the Americas, Europe Middle East Africa, and Asia Pacific markets

Regional dynamics materially influence demand drivers, regulatory requirements, and go-to-market execution for connected medical devices. In the Americas, mature reimbursement landscapes, advanced hospital infrastructure, and a strong appetite for remote monitoring combine to favor devices that demonstrate clear value in reducing acute care utilization. The region also features a dense network of private and public payers, which can accelerate adoption of devices that align with chronic disease management and post-acute care pathways. Meanwhile, supply chain logistics and proximity to component suppliers make the Americas a focal point for nearshoring and rapid product iterations.

Europe, Middle East & Africa present a heterogeneous environment where regulatory harmonization efforts coexist with divergent procurement models. In many European markets, centralized purchasing and health technology assessment processes require robust clinical and economic evidence, while Middle Eastern and African markets may present high-growth pockets driven by private hospital expansion and investment in digital health infrastructure. Across this region, data protection standards and interoperability initiatives influence device design and cloud architecture decisions, necessitating adaptable regulatory strategies and localized support models.

Asia-Pacific exhibits a broad spectrum of maturity, from advanced markets with strong domestic manufacturing ecosystems to rapidly developing healthcare systems that leapfrog legacy infrastructure through digital-first deployments. The region's scale and diversity create opportunities for scalable, lower-cost device variants and modular platforms that can be customized to local clinical needs. Additionally, the availability of contract manufacturers and electronics suppliers supports cost optimization strategies, while evolving reimbursement frameworks and large patient populations present fertile ground for remote monitoring and telehealth solutions. Taken together, regional insights underscore the need for differentiated commercialization strategies that align evidence generation, supply chain design, and partnership ecosystems to local market realities.

Analysis of incumbent and challenger company strategies highlighting platformization, partnerships, and evidence-driven commercialization to scale connected device offerings

Leading companies in the connected medical device arena demonstrate consistent patterns: integration of software and services into their core offerings, prioritization of cybersecurity and regulatory compliance, and cultivation of ecosystem partnerships to extend clinical reach. Market leaders invest in modular platforms that enable rapid feature deployment and third-party integrations, while maintaining rigorous change-management processes for software updates and post-market surveillance. Their R&D approaches emphasize clinical collaboration, pilot deployments with health systems, and iterative validation to build clinician trust and reimbursement pathways.

Smaller and mid-sized firms often compete by focusing on niche clinical problems, leveraging agility to iterate user interfaces and accelerate time-to-market. These organizations commonly pursue partnerships with cloud and analytics providers to supplement internal capabilities, and they target partnerships with channel distributors or health systems to secure initial scale. Many such firms adopt hybrid business models that combine device sales with recurring revenue from analytics subscriptions, remote monitoring services, or consumable components.

Across the competitive landscape, there is a growing trend of strategic alliances between traditional device manufacturers and digital health specialists. These collaborations accelerate access to data science capabilities, patient engagement tools, and population health platforms. At the same time, cross-industry entrants emphasize speed and experience design but must rapidly develop clinical validation processes and regulatory expertise to compete sustainably. Collectively, these company-level behaviors reveal a competitive imperative: integrate clinical evidence, robust cybersecurity, and partnership-driven distribution to scale effectively in complex care environments.

Practical strategic moves for manufacturers and providers to fortify product development, supply chain resilience, and go-to-market models for connected devices

Industry leaders should adopt a three-pronged approach that aligns product strategy, operational resilience, and market engagement to capture long-term value from connected medical devices. First, embed regulatory and clinical evidence planning at the earliest stages of product development so that software iterations, algorithm updates, and hardware revisions proceed with minimal downstream friction. Proactive planning reduces time to market for new capabilities and strengthens payor dialogues when outcomes data becomes available.

Second, redesign supply chain and sourcing strategies to increase resilience against trade disruptions and tariff-induced cost pressures. This includes diversifying component suppliers, qualifying alternate materials where feasible, and evaluating nearshoring for critical assemblies. Simultaneously, align procurement contracts to include flexibility clauses for tariff pass-throughs and establish strategic inventory buffers for key components that face volatile trade exposure.

Third, prioritize interoperability, cybersecurity, and user-centered design to accelerate adoption across care settings. Invest in open APIs, standards-based data models, and rigorous penetration testing, while conducting clinician-centered usability studies that minimize training burdens. In parallel, develop commercial models that blend capital equipment sales with subscription services, enabling predictable revenue while offering customers lower upfront costs.

Finally, cultivate strategic partnerships with payors, health systems, and technology providers to co-develop reimbursement pathways and integrated care programs. Use pilot deployments to gather real-world evidence that supports reimbursement negotiations and expands clinical indications. Executed together, these recommendations position organizations to reduce operational risk, enhance product-market fit, and convert connected device capabilities into durable commercial advantage.

Transparent research approach combining stakeholder interviews, technical assessments, regulatory reviews, and scenario testing to validate connected device insights

The research synthesis underpinning this analysis integrates primary stakeholder interviews, technical product assessments, policy and regulatory reviews, and secondary literature synthesis to produce a holistic view of the connected medical device landscape. Primary inputs included structured interviews with clinicians, procurement officers, regulatory specialists, and device engineers to ground insights in operational realities and evidence needs. These conversations were complemented by technical assessments of representative device architectures, connectivity stacks, and cybersecurity postures to surface recurring engineering constraints and integration patterns.

Regulatory and policy review processes examined current guidance on software as a medical device, cybersecurity requirements, and trade measures affecting medical technology supply chains. This review was paired with a comparative analysis of regional procurement mechanisms and reimbursement frameworks to assess how evidence thresholds and purchasing behaviors differ across markets. Secondary literature and public filings were analyzed to validate company strategies and to triangulate industry trends, while case studies of successful pilot deployments were used to illustrate pathways to scale.

Analytical methodologies combined qualitative thematic coding with scenario-based stress testing to evaluate sensitivity to tariff changes, connectivity shifts, and regulatory updates. Where applicable, evidence hierarchies were applied to weigh clinical studies, pilot outcomes, and real-world performance data. Throughout, transparency in assumptions and source provenance was maintained to enable reproducibility and to support client follow-up questions for deeper dives into specific product or regional nuances.

Concluding perspective on the systemic requirements for translating connected medical device innovation into durable clinical value and commercial success

Connected medical devices represent a pivotal frontier in healthcare transformation, offering pathways to earlier diagnosis, continuous chronic disease management, and more efficient use of clinical capacity. The confluence of advanced sensing, embedded software, and pervasive connectivity has created new expectations for product design, evidence generation, and post-market stewardship. Organizations that synchronize clinical validation, cybersecurity, and interoperability with resilient supply chains will be better positioned to scale and sustain market advantage.

Yet the path forward is complex. Tariff actions and trade uncertainty compel firms to reassess sourcing strategies and cost structures, while evolving regulatory and reimbursement landscapes require disciplined evidence planning. Market leaders are responding by platformizing offerings, forging strategic partnerships, and investing in real-world performance evidence that supports clinician adoption and payer coverage. Success will hinge on an integrated approach that aligns product development, operations, and go-to-market execution around measurable clinical and economic outcomes.

In closing, the institutions that treat connected devices as systems-where hardware, software, clinical workflows, and commercial models are co-designed-will unlock the greatest value. Those that apply rigorous risk management to supply chains and regulatory pathways, while maintaining a relentless focus on user needs and data quality, will convert technological promise into sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of end-to-end encryption protocols for connected medical devices to strengthen cybersecurity
  • 5.2. Integration of artificial intelligence algorithms for real-time analysis of patient-generated health data streams
  • 5.3. Adoption of standardized interoperability frameworks to enable seamless data exchange across healthcare platforms
  • 5.4. Deployment of edge computing architectures within medical devices to reduce latency and improve treatment responsiveness
  • 5.5. Development of battery optimization technologies to extend operational lifespan of wireless medical monitoring devices
  • 5.6. Incorporation of voice-activated control features and natural language processing in medical device interfaces to enhance accessibility

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Connected Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Systems
    • 8.1.2. Point Of Care Test Kits
    • 8.1.3. Ultrasound Devices
  • 8.2. Monitoring Devices
    • 8.2.1. ECG Monitor
    • 8.2.2. Glucose Monitor
    • 8.2.3. Vital Signs Monitor
  • 8.3. Surgical Devices
    • 8.3.1. Electrosurgical Devices
    • 8.3.2. Endoscopic Devices
    • 8.3.3. Robotic Surgery Systems
  • 8.4. Therapeutic Devices
    • 8.4.1. Dialysis Systems
    • 8.4.2. Infusion Pumps
    • 8.4.3. Ventilators
  • 8.5. Wearable Devices
    • 8.5.1. Fitness Trackers
    • 8.5.2. Smart Watches

9. Connected Medical Devices Market, by Application

  • 9.1. Drug Delivery
    • 9.1.1. Infusion Drug Delivery
    • 9.1.2. Inhalation Systems
    • 9.1.3. Injection Drug Delivery
  • 9.2. Imaging
    • 9.2.1. CT
    • 9.2.2. MRI
    • 9.2.3. Ultrasound Imaging
    • 9.2.4. X Ray
  • 9.3. Patient Monitoring
    • 9.3.1. Ambulatory Monitoring
    • 9.3.2. Critical Care Monitoring
    • 9.3.3. Remote Monitoring
  • 9.4. Rehabilitation
    • 9.4.1. Neurorehabilitation
    • 9.4.2. Occupational Therapy
    • 9.4.3. Physical Therapy
  • 9.5. Surgical Assistance
    • 9.5.1. Navigation Systems
    • 9.5.2. Robotic Assistance
  • 9.6. Telehealth
    • 9.6.1. Remote Diagnosis
    • 9.6.2. Remote Patient Monitoring
    • 9.6.3. Video Consultation

10. Connected Medical Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care Settings
    • 10.4.1. Elderly Care
    • 10.4.2. Post Operative Care
  • 10.5. Hospitals
    • 10.5.1. Private Hospitals
    • 10.5.2. Public Hospitals

11. Connected Medical Devices Market, by Connectivity Technology

  • 11.1. Bluetooth
    • 11.1.1. BLE
    • 11.1.2. Classic Bluetooth
  • 11.2. Cellular
    • 11.2.1. 2G 3G 4G
    • 11.2.2. 5G
  • 11.3. NFC
  • 11.4. Wi Fi
    • 11.4.1. 802 11ac
    • 11.4.2. 802 11n
  • 11.5. Zigbee

12. Connected Medical Devices Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Connected Medical Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Connected Medical Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Connected Medical Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke Philips N.V.
    • 16.3.2. General Electric Company
    • 16.3.3. Medtronic plc
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Johnson & Johnson
    • 16.3.6. Abbott Laboratories
    • 16.3.7. Boston Scientific Corporation
    • 16.3.8. Baxter International Inc.
    • 16.3.9. ResMed Inc.
    • 16.3.10. Dexcom, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CONNECTED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CONNECTED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONNECTED MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL CONNECTED MEDICAL DEVI